CanSino Biologics Inc. (HKG:6185)
36.54
+5.44 (17.49%)
Sep 30, 2026, 4:08 PM HKT
CanSino Biologics Employees
CanSino Biologics had 1,175 employees as of June 30, 2026. The number of employees increased by 41 or 3.62% since the number was reported on December 31, 2025.
Employees
1,175
Change
41
Growth
3.62%
Revenue / Employee
1.21M HKD
Profits / Employee
39.93K HKD
Market Cap
18.58B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 1,175 | 41 | 3.62% |
| Dec 31, 2025 | 1,134 | 29 | 2.62% |
| Dec 31, 2024 | 1,105 | -389 | -26.04% |
| Dec 31, 2023 | 1,494 | -797 | -34.79% |
| Dec 31, 2022 | 2,291 | 345 | 17.73% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| China Resources Pharmaceutical Group | 84,000 |
| The United Laboratories International Holdings | 18,000 |
| Grand Pharmaceutical Group | 12,326 |
| Simcere Pharmaceutical Group | 7,064 |
| Shandong Xinhua Pharmaceutical Company | 7,015 |
| China Medical System Holdings | 6,415 |
| Sunshine Lake Pharma | 6,299 |
| SSY Group | 5,400 |
CanSino Biologics News
- 2 months ago - Chinese drugmakers with big ambitions struggle to recruit staff for global expansion - Reuters
- 7 months ago - CanSinoBIO at WGS 2026: Accelerating Global Access to Innovative Vaccines - PRNewsWire
- 3 years ago - World-First Inhaled COVID-19 Vaccine, Developed in Partnership Between Aerogen® and CanSinoBIO, First Public Booster Immunization in China. - Business Wire
- 4 years ago - China's CanSinoBIO H1 revenue drops on weaker COVID shot demand - Reuters
- 4 years ago - CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing - PRNewsWire
- 4 years ago - CanSinoBIO Rebrands to Reflect Commitment to Life Sciences Research - PRNewsWire
- 4 years ago - CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China - PRNewsWire
- 4 years ago - CanSinoBIO's Convidecia™ Approved as Heterologous Booster in Malaysia and Indonesia - PRNewsWire